CORonavirus (COVID-19) Diagnostic Lung UltraSound Study
Launched by UNIVERSITY HOSPITAL PLYMOUTH NHS TRUST · Apr 16, 2020
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
Study participants will be screened from and recruited on their entry into the suspected COVID-19 admission pathway at Derriford Hospital, Plymouth, UK. In addition to usual clinical care (including physical exam and observations, blood tests, nasopharyngeal swab for viral PCR testing, and chest x-ray as standard), participants will undergo focused lung ultrasound examination.
Participants who are negative for COVID-19 will be followed up to confirm their final discharge diagnoses, and clinical outcome at either 3 months post-enrolment or discharge from hospital.
Participants who are posi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 18 years
- • Suspected or confirmed diagnosis of COVID-19
- • Able to provide informed consent to study participation
- Exclusion Criteria:
- • Age less than 18 years
- • Inability to provide informed consent at the time of study enrolment
About University Hospital Plymouth Nhs Trust
University Hospital Plymouth NHS Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust facilitates innovative studies across various therapeutic areas, fostering collaboration between clinical teams and academic partners. Committed to enhancing patient outcomes, the Trust emphasizes ethical research practices, patient safety, and adherence to regulatory standards, while contributing to the development of new treatments and healthcare solutions. Through its robust infrastructure and experienced personnel, University Hospital Plymouth NHS Trust plays a pivotal role in shaping the future of healthcare through rigorous clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Plymouth, Devon, United Kingdom
Patients applied
Trial Officials
John P Corcoran, BMBCh MRCP
Principal Investigator
University Hospitals Plymouth NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials